Menu
Merck and Aurobindo Pharma recently announced refunds for 340B covered entities.

Merck, Aurobino Pharma to Refund 340B Covered Entities for Overcharges

Shannon Young, Managing Editor 340B Report Views
Two drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2022 and 2024, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Federal Government Shutdown Could Impact 340B Rebate Model Pilot’s Rollout and Other Key 340B Operations

State Contract Pharmacy Lawsuit Roundup: Updates in Mississippi, Nebraska and Colorado

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live